However, BCR, continuously increasing PSA levels in patients with and without ADT, and a PSA relapse over time after an initial treatment effect in patients receiving ADT require effective staging procedures for recurrent prostate cancer (PC). The gene discussed is KLK3; the disease is Familial prostate cancer.